SCHEMBL30487159

SCHEMBL30487159

CN1CCN(c2cc(S(=O)(=O)c3ccc(Cl)c(C(F)(F)F)c3)ccc2-n2cn[nH]c2=S)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ HSD11B1 P28845 4/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ ADORA3 P0DMS8 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HTR6 P50406 1/20 0.35
▸ PTGS2 P35354 1/20 0.35
▸ BRD4 O60885 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21378310 1.00 MEN1 (0.39) MEN1KMT2ALMNAPOLBMAPT
SCHEMBL30487158 0.92 MEN1 (0.39) MEN1KMT2ALMNAPOLBMAPT
SCHEMBL21378264 0.92 MEN1 (0.39) MEN1KMT2ALMNAPOLBMAPT
SCHEMBL21378330 0.91 MEN1 (0.39) MEN1KMT2ALMNAPOLBMAPT
SCHEMBL30487150 0.91 MEN1 (0.39) MEN1KMT2ALMNAPOLBMAPT
SCHEMBL28540015 0.89 SMN1; SMN2 (0.39) MEN1KMT2ALMNAPOLBMAPT
SCHEMBL21378296 0.89 NOTUM (0.38) MEN1KMT2ALMNAPOLBMAPT
SCHEMBL30487164 0.89 NOTUM (0.38) MEN1KMT2ALMNAPOLBMAPT
SCHEMBL25891490 0.87 LMNA (0.39) LMNAPOLBMAPTMAPK1HTR6
SCHEMBL21378303 0.81 TDP1 (0.53) MEN1KMT2ALMNAPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230391734-A1 SUBSTITUTED PHENYL SULFONYL PHENYL TRIAZOLE THIONES AND USES THEREOF NEUROPORE THERAPIES, INC. (US) 2023-12-07 — — US claimed
US-11708338-B2 Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof NEUROPORE THERAPIES, INC. (US) 2023-07-25 — — US claimed
US-20230391734-A1 SUBSTITUTED PHENYL SULFONYL PHENYL TRIAZOLE THIONES AND USES THEREOF NEUROPORE THERAPIES, INC. (US) 2023-12-07 — — US disclosed
US-11708338-B2 Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof NEUROPORE THERAPIES, INC. (US) 2023-07-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11708338-B2 Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof TPMT, ABCB1, DPP8 MEN1 4273/4885KMT2A 3726/4885LMNA 4022/4885
US-20230391734-A1 SUBSTITUTED PHENYL SULFONYL PHENYL TRIAZOLE THIONES AND USES THEREOF TPMT, ABCB1, DPP8 MEN1 4273/4885KMT2A 3726/4885LMNA 4022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback